首页 正文

HER2 alterations in non-small cell lung cancer (NSCLC): from biology and testing to advances in treatment modalities

{{output}}
Lung cancer remains the leading cause of cancer-related deaths worldwide. Non-small cell lung cancer (NSCLC), which accounts for approximately 85% of all lung cancers, is a biologically diverse disease characterized by a wide range of molecular alterations. Am... ...